Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD.

Singh D, Nicolini G, Bindi E, Corradi M, Guastalla D, Kampschulte J, Pierzchała W, Sayiner A, Szilasi M, Terzano C, Vestbo J; FUTURE (Foster Upgrades TherapeUtic care in REspiratory disease) study group..

BMC Pulm Med. 2014 Mar 12;14:43. doi: 10.1186/1471-2466-14-43.

2.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators..

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342.

3.

A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations.

Singh D, Kampschulte J, Wedzicha JA, Jones PW, Cohuet G, Corradi M, Higenbottam T, Petruzzelli S, Vestbo J.

Eur Respir J. 2013 Jan;41(1):12-7. doi: 10.1183/09031936.00207611.

4.

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators..

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.

5.

Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.

Virchow JC, Mehta A, Ljungblad L, Mitfessel H; MONICA study group..

Respir Med. 2010 May;104(5):644-51. doi: 10.1016/j.rmed.2009.11.022.

6.

[Helicobacter pylori: antibodies in sera of pigs and calves].

Seidel KE, Kampschulte J, Lehn N, Bauer J.

Berl Munch Tierarztl Wochenschr. 1996 Nov-Dec;109(11-12):434-9. German.

PMID:
8999777

Supplemental Content

Loading ...
Support Center